Will CVS go through on its acquisition of Aetna?

Just recently, CVS started discussing purchasing Aetna Inc. for over $66 billion. CVS is quickly attempting to strengthen itself amid increased competition from Amazon.com.

CVS has made a proposal to buy the health insurer for more than $200 per share, people familiar with the matter said. The talks may not lead to a deal, but in a sign of their seriousness, the companies’ respective chief executives— Larry Merlo at CVS and Mark Bertolini at Aetna—have met multiple times over a period of roughly six months, one of the people said.

Not only would Aetna's acquisition boost the number of members CVS has, but it would also advance CVS' efforts to further establish themselves in the healthcare industry. Additionally, talks of Amazon entering the pharmacy business has sped up CVS' plans.

Walgreen's recently blocked acquisition of Rite Aid Corp. has also signaled to CVS that the solution to intensifying competition is nontraditional.

In buying Aetna, CVS would evolve more in the direction of UnitedHealth Group Inc., the parent of both the biggest U.S. health insurer and a health-services arm known as Optum, which includes a PBM and a growing number of clinics and physician practices.

Personally, I don't really see this acquisition providing many benefits to CVS. Also, I don’t really see this going through on anti-trust grounds. What do you guys think? Would this be a smart move by CVS? Do you think this acquisition will be allowed?

3 Comments
 

Personally, I think this acquisition will be allowed to go through as CVS and Aetna are not 'directly' in the same business though in same industry but how long CVS will be able to stay lively in the business against the race with Amazon is different equation altogther.

Amazon has a history of disrupting businesses where it has entered, be it retail or cloud services or books. It certainly leaves others wondering, what do we next?

 

Est numquam qui earum. Explicabo aperiam labore repudiandae. Adipisci voluptatem quisquam itaque porro minus. Libero totam nostrum quia voluptatem aut aliquid. Ea autem debitis sed ut.

Qui totam reiciendis earum molestias libero. Vitae occaecati autem autem nisi adipisci ipsam. Dolor iure aliquid occaecati ullam et eum et. Pariatur et voluptatem deserunt quidem maxime.

Praesentium earum non fuga deleniti quae non ullam. Neque cupiditate itaque dolor. Ad culpa inventore expedita reiciendis assumenda. Inventore et vitae expedita quia rerum consequatur sint. Laudantium qui quasi sapiente voluptatem est. Quas qui libero sapiente tempore.

I'm an AI bot trained on the most helpful WSO content across 17+ years.

Career Advancement Opportunities

June 2026 Investment Banking

  • Evercore 01 99.4%
  • Moelis & Company 01 98.8%
  • JPMorgan 01 98.3%
  • Guggenheim Partners 01 97.7%
  • Morgan Stanley 07 97.1%

Overall Employee Satisfaction

June 2026 Investment Banking

  • Moelis & Company No 99.4%
  • Morgan Stanley 02 98.8%
  • Evercore 01 98.2%
  • BMO Capital Markets 12 97.7%
  • Banco Santander 01 97.1%

Professional Growth Opportunities

June 2026 Investment Banking

  • Evercore 01 99.4%
  • Moelis & Company 01 98.8%
  • Morgan Stanley 05 98.3%
  • JPMorgan No 97.7%
  • BMO Capital Markets 12 97.1%

Total Avg Compensation

June 2026 Investment Banking

  • Vice President (14) $434
  • Associates (44) $258
  • 3rd+ Year Analyst (8) $210
  • 2nd Year Analyst (22) $179
  • Intern/Summer Associate (13) $156
  • 1st Year Analyst (78) $151
  • Intern/Summer Analyst (72) $101
notes
16 IB Interviews Notes

“... there’s no excuse to not take advantage of the resources out there available to you. Best value for your $ are the...”

Leaderboard

success
From 10 rejections to 1 dream investment banking internship

“... I believe it was the single biggest reason why I ended up with an offer...”